Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Boris Reva
Affiliation
Icahn School of Medicine at Mount Sinai
ORCID
Career Start Year
1990
Papers
62
H Index
27
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37057291
The most likely but largely ignored triggering factor for breast (or all) cancer invasion.
J Cancer
2023
37057291
The most likely but largely ignored triggering factor for breast (or all) cancer invasion.
J Cancer
2023
37541199
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer.
Cell
2023
37541199
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer.
Cell
2023
35881881
Reprogrammed Schwann Cells Organize into Dynamic Tracks that Promote Pancreatic Cancer Invasion.
Cancer Discov
2022
35881881
Reprogrammed Schwann Cells Organize into Dynamic Tracks that Promote Pancreatic Cancer Invasion.
Cancer Discov
2022
35681714
Association between Incidental Pelvic Inflammation and Aggressive Prostate Cancer.
Cancers (Basel)
2022
35681714
Association between Incidental Pelvic Inflammation and Aggressive Prostate Cancer.
Cancers (Basel)
2022
33577785
Proteogenomic and metabolomic characterization of human glioblastoma.
Cancer Cell
2021
33577785
Proteogenomic and metabolomic characterization of human glioblastoma.
Cancer Cell
2021
32510176
ProTrack: An Interactive Multi-Omics Data Browser for Proteogenomic Studies.
Proteomics
2020
31923397
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.
Cell
2020
33446324
Immune Escape in Prostate Cancer: Known and Predicted Mechanisms and Targets.
Urol Clin North Am
2020
32510176
ProTrack: An Interactive Multi-Omics Data Browser for Proteogenomic Studies.
Proteomics
2020
31923397
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.
Cell
2020
33446324
Immune Escape in Prostate Cancer: Known and Predicted Mechanisms and Targets.
Urol Clin North Am
2020
30651579
Nonsyndromic craniosynostosis: novel coding variants.
Pediatr Res
2019
31675502
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.
Cell
2019
30651579
Nonsyndromic craniosynostosis: novel coding variants.
Pediatr Res
2019
31675502
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.
Cell
2019
30301868
Detection of endometrial precancer by a targeted gynecologic cancer liquid biopsy.
Cold Spring Harb Mol Case Stud
2018
30301868
Detection of endometrial precancer by a targeted gynecologic cancer liquid biopsy.
Cold Spring Harb Mol Case Stud
2018
28974674
Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomas.
Nat Commun
2017
32913967
Identification and Functional Characterization of <i>EGFR</i> V769M, a Novel Germline Variant Associated With Multiple Lung Adenocarcinomas.
JCO Precis Oncol
2017
28974674
Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomas.
Nat Commun
2017
32913967
Identification and Functional Characterization of <i>EGFR</i> V769M, a Novel Germline Variant Associated With Multiple Lung Adenocarcinomas.
JCO Precis Oncol
2017
26910679
Mutation Screening of Candidate Genes in Patients with Nonsyndromic Sagittal Craniosynostosis.
Plast Reconstr Surg
2016
27245685
Development and clinical application of an integrative genomic approach to personalized cancer therapy.
Genome Med
2016
27098033
A new molecular signature method for prediction of driver cancer pathways from transcriptional data.
Nucleic Acids Res
2016
26910679
Mutation Screening of Candidate Genes in Patients with Nonsyndromic Sagittal Craniosynostosis.
Plast Reconstr Surg
2016
26619149
Strand-specific in vivo screen of cancer-associated miRNAs unveils a role for miR-21(â¿¿) in SCC progression.
Nat Cell Biol
2016
28027320
Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study.
PLoS Med
2016
26619149
Strand-specific in vivo screen of cancer-associated miRNAs unveils a role for miR-21(â¿¿) in SCC progression.
Nat Cell Biol
2016
28027320
Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study.
PLoS Med
2016
27245685
Development and clinical application of an integrative genomic approach to personalized cancer therapy.
Genome Med
2016
27098033
A new molecular signature method for prediction of driver cancer pathways from transcriptional data.
Nucleic Acids Res
2016
25351745
MAP2K1 (MEK1) Mutations Define a Distinct Subset of Lung Adenocarcinoma Associated with Smoking.
Clin Cancer Res
2015
25351745
MAP2K1 (MEK1) Mutations Define a Distinct Subset of Lung Adenocarcinoma Associated with Smoking.
Clin Cancer Res
2015
24436421
Direct in vivo RNAi screen unveils myosin IIa as a tumor suppressor of squamous cell carcinomas.
Science
2014
25521405
Clinical and in vivo evidence that EGFR S768I mutant lung adenocarcinomas are sensitive to erlotinib.
J Thorac Oncol
2014
24346104
Unsuspected collision of synchronous lung adenocarcinomas: a potential cause of aberrant driver mutation profiles.
J Thorac Oncol
2014
24436421
Direct in vivo RNAi screen unveils myosin IIa as a tumor suppressor of squamous cell carcinomas.
Science
2014
25010664
Genetic variation in DNA repair pathways and risk of non-Hodgkin's lymphoma.
PLoS One
2014
25521405
Clinical and in vivo evidence that EGFR S768I mutant lung adenocarcinomas are sensitive to erlotinib.
J Thorac Oncol
2014
25010664
Genetic variation in DNA repair pathways and risk of non-Hodgkin's lymphoma.
PLoS One
2014
24346104
Unsuspected collision of synchronous lung adenocarcinomas: a potential cause of aberrant driver mutation profiles.
J Thorac Oncol
2014
23371856
EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics.
Mol Cancer Ther
2013
24220575
Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif.
Nat Commun
2013
23819556
Revealing selection in cancer using the predicted functional impact of cancer mutations. Application to nomination of cancer drivers.
BMC Genomics
2013
23900255
Computational approaches to identify functional genetic variants in cancer genomes.
Nat Methods
2013
1 - 50 of 124
Column Actions
Search
Recommended Authors
Lucy J Colwell
Google Research
Career Start Year
2009
Number of shared co-authors
2
Jaume Bonet
Institute of Bioengineering, Ecole Polytechnique Federale de Lausanne
Career Start Year
2006
Number of shared co-authors
0
Narcis Fernandez-Fuentes
Institute of Biological, Aberystwyth University
Career Start Year
2002
Number of shared co-authors
0
Jun-Tao Guo
University of North Carolina at Charlotte
Career Start Year
1999
Number of shared co-authors
0
Nikolay V Dokholyan
Pennsylvania State University College of Medicine
Career Start Year
1998
Number of shared co-authors
2
Daron M Standley
Osaka university
Career Start Year
1998
Number of shared co-authors
0
Mallur S Madhusudhan
Indian Institute of Science Education and Research Pune
Career Start Year
1996
Number of shared co-authors
2
Jooyoung Lee
Korea Institute for Advanced Study
Career Start Year
1996
Number of shared co-authors
0
Robert B Russell
Heidelberg University
Career Start Year
1991
Number of shared co-authors
3
Baldo Oliva
Universitat Pompeu Fabra
Career Start Year
1991
Number of shared co-authors
2
Carlos J Camacho
University of Pittsburgh
Career Start Year
1990
Number of shared co-authors
0
Ram Samudrala
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Career Start Year
1990
Number of shared co-authors
0
Paul A Bates
The Francis Crick Institute
Career Start Year
1989
Number of shared co-authors
1
Roland L Dunbrack
Fox Chase Cancer Center
Career Start Year
1989
Number of shared co-authors
1
David Baker
University of Washington
Career Start Year
1988
Number of shared co-authors
1
Miriam Eisenstein
Weizmann Institute of Science
Career Start Year
1988
Number of shared co-authors
0
Jadwiga Bienkowska
Pfizer Global Research and Development La Jolla
Career Start Year
1987
Number of shared co-authors
0
Adam Godzik
University of California Riverside
Career Start Year
1987
Number of shared co-authors
18
Andrej Sali (CM4AI)
University of California San Francisco
Career Start Year
1985
Number of shared co-authors
7
Mark S Johnson
Abo Akademi University
Career Start Year
1985
Number of shared co-authors
0
Ruth Nussinov
Sackler School of Medicine, Tel Aviv University
Career Start Year
1980
Number of shared co-authors
1
Haruki Nakamura
Institute for Protein Research, Osaka University
Career Start Year
1980
Number of shared co-authors
1
Michael J E Sternberg
Imperial College London
Career Start Year
1976
Number of shared co-authors
2
Shoshana J Wodak
VIB-VUB Center for Structural Biology
Career Start Year
1975
Number of shared co-authors
3
Rita Casadio
Department of Pharmacy and Biotechnology, University of Bologna
Career Start Year
1974
Number of shared co-authors
4
Tom L Blundell
Heartand Lung Research Institute, University of Cambridge
Career Start Year
1971
Number of shared co-authors
0
Barry Honig
Columbia University Irving Medical Center
Career Start Year
1971
Number of shared co-authors
1
John Moult
Institute for Bioscience and Biotechnology Research
Career Start Year
1970
Number of shared co-authors
6
Michael Levitt
Stanford University
Career Start Year
1969
Number of shared co-authors
1
Andras Fiser
Albert Einstein College of Medicine
Career Start Year
1968
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Chris Sander
Broad Institute of MIT and Harvard
Co-authored papers
12
Eric E Schadt
Icahn School of Medicine at Mount Sinai
Co-authored papers
6
Arthur J Olson
Co-authored papers
6
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
Co-authored papers
6
Dmitry Rykunov
Co-authored papers
6
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
5
Tatiana Omelchenko
Co-authored papers
5
Francesca Petralia
Co-authored papers
5
Azra Krek
Co-authored papers
4
Pei Wang
Co-authored papers
4
Seungyeul Yoo
Co-authored papers
4
Bing Zhang
Baylor College of Medicine
Co-authored papers
4
Alexey I Nesvizhskii
University of Michigan ann arbor
Co-authored papers
4
Mehdi Mesri
Co-authored papers
4
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Co-authored papers
4
David Feny??
Institute for Systems Genetics, NYU Grossman School of Medicine
Co-authored papers
4
Weiping Ma
Co-authored papers
4
Yize Li
Co-authored papers
3
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Co-authored papers
3
Marcin Cieslik
Co-authored papers
3
Andrew V Uzilov
University of California Santa Cruz
Co-authored papers
3
Kelly V Ruggles
Co-authored papers
3
Felipe da Veiga Leprevost
University of Michigan ann arbor
Co-authored papers
3
Maciej Wiznerowicz
Co-authored papers
3
Jiayi Ji
Co-authored papers
3
Robert Sebra
Icahn School of Medicine at Mount Sinai
Co-authored papers
3
Tara Hiltke
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Co-authored papers
3
Mathangi Thiagarajan
Co-authored papers
3
James J Hsieh
Washington University
Co-authored papers
3
Saravana M Dhanasekaran
Co-authored papers
3
1 - 30